Cargando…

A NIR‐II Photoactivatable “ROS Bomb” with High‐Density Cu(2)O‐Supported MoS(2) Nanoflowers for Anticancer Therapy

The fast conversion of hydrogen peroxide (H(2)O(2)) into reactive oxygen species (ROS) at tumor sites is a promising anticancer strategy by manipulating nanomedicines with near‐infrared light in the second region (NIR‐II). However, this strategy is greatly compromised by the powerful antioxidant cap...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jia, Deng, Guiming, Wang, Shuya, Zhao, Tianjiao, Chen, Qiaohui, Yang, Yuqi, Yang, Yongqi, Zhang, Jinping, Nan, Yayun, Liu, Zhaoqian, Cao, Ke, Huang, Qiong, Ai, Kelong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460899/
https://www.ncbi.nlm.nih.gov/pubmed/37340606
http://dx.doi.org/10.1002/advs.202302208
Descripción
Sumario:The fast conversion of hydrogen peroxide (H(2)O(2)) into reactive oxygen species (ROS) at tumor sites is a promising anticancer strategy by manipulating nanomedicines with near‐infrared light in the second region (NIR‐II). However, this strategy is greatly compromised by the powerful antioxidant capacity of tumors and the limited ROS generation rate of nanomedicines. This dilemma mainly stems from the lack of an effective synthesis method to support high‐density copper‐based nanocatalysts on the surface of photothermal nanomaterials. Herein, a multifunctional nanoplatform (MCPQZ) with high–density cuprous (Cu(2)O) supported molybdenum disulfide (MoS(2)) nanoflowers (MC NFs) is developed for the efficient killing of tumors via a potent ROS storm by an innovative method. Under NIR‐II light irradiation, the ROS intensity and maximum reaction velocity (V (max)) produced by MC NFs are 21.6 and 33.8 times that of the non–irradiation group in vitro, which is much higher than most current nanomedicines. Moreover, the strong ROS storm in cancer cells is efficiently formed by MCPQZ (increased by 27.8 times compared to the control), thanks to the fact that MCPQZ effectively pre–weakens the multiple antioxidant systems of cancer cells. This work provides a novel insight to solve the bottleneck of ROS‐based cancer therapy.